Compare Roivant Sciences Ltd. Common Shares (ROIV) vs Trane Technologies plc (TT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roivant Sciences Ltd. Common Shares vs Trane Technologies plc — how do they compare? Roivant Sciences Ltd. Common Shares trades at $33.9 (market cap $24.99B), while Trane Technologies plc trades at $471.85 (market cap $103.69B). The key difference: Trane Technologies plc is far larger — about 4.1× Roivant Sciences Ltd. Common Shares's market cap, and Trane Technologies plc pays a 0.89% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals.
| ROIV | TT | |
|---|---|---|
Market Cap | $24.99B | $103.69B |
Volume | 4,711,562 | 922,354 |
Sector | Health | Industrials |
52-Week High | $41.81 | $503.46 |
52-Week Low | $16.99 | $376.43 |
Typical Hold Time | 3 Days | — |
Enterprise Value | $21.25B | $106.99B |
Dividend Yield | — | 0.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Roivant Sciences (ROIV) trades at $33.35, down 3.58% on the day amid a bearish technical signal. The stock faces fundamental headwinds with a net loss of $172 million in 2025 and negative cash flow, though recent news highlights pipeline progress including positive Phase 2 data for mosliciguat in PH-ILD. Analyst sentiment remains strongly bullish with a consensus price target of $46.75.
The outlook hinges on clinical execution; upside exists if pipeline assets like LISRAYA launch successfully, but high cash burn and profitability challenges pose significant risks. Near-term price action is pressured, but long-term value depends on converting R&D into commercial success.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →About Trane Technologies plc
Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →
